Perry probed by SEC on Mylan Labs deal
Fri Jan 13, 2006
New York-based Perry Capital may face civil charges stemming
from allegations that the $11.5 billion hedge fund shop
violated securities laws in connection with the firm's
investment in Mylan Laboratories.
In a "Wells notice" sent to Perry Capital, the...
ISSN: 2151-1845 / CDC10004H
The full contents of this article are available to active AR subscribers and trialists only.
TAKE A FREE TRIAL
To continue reading please, take a free trial, subscribe or log in to AR.
Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.